HK Stock MarketDetailed Quotes

01528 RS MACALLINE

Watchlist
  • 1.210
  • 0.0000.00%
Market Closed Jul 24 16:08 CST
5.27BMarket Cap-1617P/E (TTM)

RS MACALLINE Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Cash flow from operating activities
Earning before tax
----
-258.96%-2.54B
----
-83.26%288.2M
----
-40.48%1.6B
----
4.68%1.72B
----
30.05%2.68B
Profit adjustment
Interest (income) - adjustment
----
27.43%-167.32M
----
33.33%-79.57M
----
-1.49%-230.57M
----
---119.36M
----
---227.2M
Dividend (income)- adjustment
----
-25.32%-53.68M
----
-201.75%-34.54M
----
-1,198.09%-42.84M
----
---11.45M
----
---3.3M
Attributable subsidiary (profit) loss
----
-393.97%-77.7M
----
-142.86%-88.77M
----
158.49%26.43M
----
---36.55M
----
---45.19M
Impairment and provisions:
--0
95.48%1.88B
--0
48.85%252.25M
--0
27.52%960.03M
--0
2,111.65%169.47M
--0
63.84%752.84M
-Impairmen of inventory (reversal)
----
--92.14M
----
----
----
----
----
----
----
----
-Other impairments and provisions
----
85.88%1.78B
----
48.85%252.25M
----
27.52%960.03M
----
--169.47M
----
--752.84M
Revaluation surplus:
--0
113.78%1.59B
--0
48.12%323.03M
--0
198.33%744.03M
--0
196.06%218.08M
--0
150.47%249.4M
-Fair value of investment properties (increase)
----
113.00%1.55B
----
30.83%296.25M
----
194.19%725.83M
----
--226.43M
----
--246.73M
-Other fair value changes
----
144.84%44.56M
----
420.76%26.78M
----
581.90%18.2M
----
---8.35M
----
--2.67M
Asset sale loss (gain):
--0
2,643.90%88.83M
--0
676.59%51.15M
--0
99.31%-3.49M
--0
142.02%6.59M
--0
-36,732.35%-504.15M
-Loss (gain) from sale of subsidiary company
----
26,455.93%77.75M
----
392.21%35.9M
----
99.94%-295K
----
--7.29M
----
---487.88M
-Loss (gain) on sale of property, machinery and equipment
----
446.07%11.06M
----
2,256.86%15.25M
----
76.46%-3.2M
----
95.49%-707K
----
-892.36%-13.58M
-Loss (gain) from selling other assets
----
--19K
----
----
----
----
----
----
----
---2.69M
Depreciation and amortization:
--0
-14.12%318.14M
--0
-7.90%173.22M
--0
-9.70%370.43M
--0
3.27%188.07M
--0
9.98%410.22M
-Depreciation
----
-16.04%277.28M
----
-9.14%152.8M
----
-8.71%330.25M
----
--168.17M
----
--361.78M
-Amortization of intangible assets
----
1.68%40.86M
----
2.59%20.42M
----
-17.05%40.18M
----
-15.20%19.91M
----
17.86%48.44M
Financial expense
----
6.04%2.65B
----
0.51%1.26B
----
-7.10%2.5B
----
9.11%1.25B
----
13.90%2.69B
Exchange Loss (gain)
----
--29.49M
----
----
----
----
----
----
----
----
Special items
----
197.38%51.9M
----
--48.41M
----
-158.62%-53.3M
----
----
----
--90.92M
Operating profit before the change of operating capital
--0
-35.76%3.77B
--0
-35.33%2.19B
--0
-3.78%5.87B
--0
--3.39B
--0
--6.1B
Change of operating capital
Inventory (increase) decrease
----
62.83%42.69M
----
889.21%31.63M
----
3,410.48%26.22M
----
112.09%3.2M
----
-129.52%-792K
Accounts receivable (increase)decrease
----
403.71%625.47M
----
475.17%262.27M
----
-127.03%-205.94M
----
89.84%-69.91M
----
204.07%761.87M
Accounts payable increase (decrease)
----
-3.09%-346.66M
----
85.00%-64.47M
----
66.42%-336.27M
----
-339.71%-429.86M
----
-474.66%-1B
Advance payment increase (decrease)
----
100.37%2.99M
----
139.87%314.8M
----
-211.88%-818.82M
----
---789.66M
----
--731.89M
Cash  from business operations
--0
-25.47%3.09B
--0
4.41%2.3B
--0
-30.89%4.14B
--0
--2.2B
--0
--5.99B
Other taxs
----
-175.74%-722.7M
----
-15.00%-230.09M
----
57.12%-262.09M
----
---200.07M
----
---611.25M
Adjustment items of business operations
-116.88%-181.67M
----
-30.37%2.77B
----
-14.59%1.08B
----
-16.72%3.98B
----
71.14%1.26B
----
Net cash from operations
-116.88%-181.67M
-39.07%2.36B
-30.37%2.77B
3.35%2.07B
-14.59%1.08B
-27.91%3.88B
-16.72%3.98B
-3.96%2B
71.14%1.26B
29.35%5.38B
Cash flow from investment activities
Interest received - investment
----
-95.00%11.53M
----
-75.67%9.36M
----
1.49%230.57M
----
--38.48M
----
--227.2M
Dividend received - investment
----
111.37%90.54M
----
144.11%44.88M
----
298.74%42.84M
----
-93.27%18.39M
----
-81.56%10.74M
Loan receivable (increase) decrease
----
-13,925.62%-186.68M
----
21.01%6.06M
----
-100.53%-1.33M
----
--5.01M
----
--252.2M
Decrease in deposits (increase)
----
-130.61%-148.62M
----
-112.91%-34.21M
----
343.07%485.52M
----
--265.02M
----
---199.75M
Sale of fixed assets
----
147.47%120.27M
----
6,586.14%118.68M
----
117.42%48.6M
----
-90.73%1.78M
----
81.83%22.35M
Purchase of fixed assets
----
80.04%-40.24M
----
89.51%-44.58M
----
53.40%-201.6M
----
69.51%-425.08M
----
85.07%-432.57M
Selling intangible assets
----
-98.28%235K
----
--306K
----
6,292.06%13.68M
----
----
----
--214K
Purchase of intangible assets
----
96.03%-1.34M
----
-1,458.28%-15.05M
----
-333.92%-33.8M
----
---966K
----
---7.79M
Sale of subsidiaries
----
370.18%633.97M
----
989.88%81.52M
----
-74.68%134.83M
----
-95.36%7.48M
----
53,248,699,900.00%532.49M
Acquisition of subsidiaries
----
---12.5M
----
----
----
----
----
22.58%-5.5M
----
66.02%-544.1M
Recovery of cash from investments
----
-84.57%491.98M
----
-27.20%851.77M
----
-37.31%3.19B
----
118.61%1.17B
----
205.63%5.09B
Cash on investment
----
61.95%-309.73M
----
41.68%-196.2M
----
79.97%-814.01M
----
-66.49%-336.44M
----
-394.60%-4.06B
Other items in the investment business
-302.38%-470.84M
102.16%51.94M
214.35%536M
86.58%-88.06M
-42.78%232.66M
-138.30%-2.41B
-91.98%170.51M
-214.39%-656.3M
262.58%406.62M
20.29%-1.01B
Net cash from investment operations
-302.38%-470.84M
1.99%701.36M
214.35%536M
797.67%734.47M
-42.78%232.66M
642.29%687.7M
-91.98%170.51M
301.74%81.82M
262.58%406.62M
97.39%-126.81M
Net cash before financing
-149.85%-652.52M
-32.88%3.07B
-20.30%3.3B
34.55%2.8B
-21.47%1.31B
-13.08%4.57B
-39.91%4.15B
1.95%2.08B
242.82%1.67B
859.15%5.25B
Cash flow from financing activities
New borrowing
----
9.44%12.21B
----
-66.11%2.59B
----
-22.24%11.16B
----
23.77%7.63B
----
-22.89%14.35B
Refund
----
5.29%-12.18B
----
50.20%-3.49B
----
21.02%-12.86B
----
17.68%-7B
----
-11.48%-16.28B
Issuing shares
----
----
----
----
----
----
----
----
----
--3.68B
Issuance of bonds
----
----
----
----
----
--1.7B
----
----
----
----
Interest paid - financing
----
10.85%-2.22B
----
15.72%-1.25B
----
0.40%-2.49B
----
---1.48B
----
---2.5B
Dividends paid - financing
----
70.79%-167.78M
----
76.54%-17.21M
----
-168.73%-574.31M
----
94.96%-73.35M
----
94.36%-213.72M
Absorb investment income
----
11,088.83%305.46M
----
----
----
-96.50%2.73M
----
-96.71%2.23M
----
293.14%78.04M
Issuance expenses and redemption of securities expenses
----
87.17%-530.83M
----
66.61%-500.83M
----
-3.06%-4.14B
----
---1.5B
----
---4.01B
Other items of the financing business
196.62%1.45B
31.83%-582.45M
44.70%-2.79B
-51.42%-247.27M
21.76%-1.5B
-481.20%-854.4M
28.30%-5.05B
-181.24%-163.3M
-128.37%-1.92B
64.44%-147.01M
Net cash from financing operations
196.62%1.45B
60.72%-3.17B
44.70%-2.79B
-12.63%-2.91B
21.76%-1.5B
-59.47%-8.06B
28.30%-5.05B
26.71%-2.59B
-128.37%-1.92B
-2,678.28%-5.05B
Effect of rate
60.21%-292.92K
-118.05%-510K
-78.75%351.58K
1,283.02%627K
25.24%-736.13K
185.66%2.83M
1,128.30%1.65M
85.38%-53K
-126.83%-984.63K
-209.77%-3.3M
Net Cash
514.79%798.1M
97.11%-100.95M
156.17%509.64M
78.06%-110.47M
23.69%-192.41M
-1,844.33%-3.49B
-511.72%-907.33M
66.12%-503.52M
28.78%-252.14M
122.91%200.22M
Begining period cash
-3.89%2.51B
-57.23%2.61B
-57.23%2.61B
-57.23%2.61B
-57.23%2.61B
3.34%6.1B
3.34%6.1B
3.34%6.1B
3.34%6.1B
-12.91%5.9B
Cash at the end
36.83%3.3B
-3.89%2.51B
-39.94%3.12B
-55.34%2.5B
-58.68%2.42B
-57.23%2.61B
-9.74%5.19B
26.73%5.59B
5.30%5.84B
3.34%6.1B
Cash balance analysis
Cash and cash equivalent balance
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
National Health Certified Public Accountants Limited, ZTE Caiguanghua Certified Public Accountants (Special General Partnership)
--
--
--
National Health Certified Public Accountants Limited, ZTE Caiguanghua Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Cash flow from operating activities
Earning before tax -----258.96%-2.54B-----83.26%288.2M-----40.48%1.6B----4.68%1.72B----30.05%2.68B
Profit adjustment
Interest (income) - adjustment ----27.43%-167.32M----33.33%-79.57M-----1.49%-230.57M-------119.36M-------227.2M
Dividend (income)- adjustment -----25.32%-53.68M-----201.75%-34.54M-----1,198.09%-42.84M-------11.45M-------3.3M
Attributable subsidiary (profit) loss -----393.97%-77.7M-----142.86%-88.77M----158.49%26.43M-------36.55M-------45.19M
Impairment and provisions: --095.48%1.88B--048.85%252.25M--027.52%960.03M--02,111.65%169.47M--063.84%752.84M
-Impairmen of inventory (reversal) ------92.14M--------------------------------
-Other impairments and provisions ----85.88%1.78B----48.85%252.25M----27.52%960.03M------169.47M------752.84M
Revaluation surplus: --0113.78%1.59B--048.12%323.03M--0198.33%744.03M--0196.06%218.08M--0150.47%249.4M
-Fair value of investment properties (increase) ----113.00%1.55B----30.83%296.25M----194.19%725.83M------226.43M------246.73M
-Other fair value changes ----144.84%44.56M----420.76%26.78M----581.90%18.2M-------8.35M------2.67M
Asset sale loss (gain): --02,643.90%88.83M--0676.59%51.15M--099.31%-3.49M--0142.02%6.59M--0-36,732.35%-504.15M
-Loss (gain) from sale of subsidiary company ----26,455.93%77.75M----392.21%35.9M----99.94%-295K------7.29M-------487.88M
-Loss (gain) on sale of property, machinery and equipment ----446.07%11.06M----2,256.86%15.25M----76.46%-3.2M----95.49%-707K-----892.36%-13.58M
-Loss (gain) from selling other assets ------19K-------------------------------2.69M
Depreciation and amortization: --0-14.12%318.14M--0-7.90%173.22M--0-9.70%370.43M--03.27%188.07M--09.98%410.22M
-Depreciation -----16.04%277.28M-----9.14%152.8M-----8.71%330.25M------168.17M------361.78M
-Amortization of intangible assets ----1.68%40.86M----2.59%20.42M-----17.05%40.18M-----15.20%19.91M----17.86%48.44M
Financial expense ----6.04%2.65B----0.51%1.26B-----7.10%2.5B----9.11%1.25B----13.90%2.69B
Exchange Loss (gain) ------29.49M--------------------------------
Special items ----197.38%51.9M------48.41M-----158.62%-53.3M--------------90.92M
Operating profit before the change of operating capital --0-35.76%3.77B--0-35.33%2.19B--0-3.78%5.87B--0--3.39B--0--6.1B
Change of operating capital
Inventory (increase) decrease ----62.83%42.69M----889.21%31.63M----3,410.48%26.22M----112.09%3.2M-----129.52%-792K
Accounts receivable (increase)decrease ----403.71%625.47M----475.17%262.27M-----127.03%-205.94M----89.84%-69.91M----204.07%761.87M
Accounts payable increase (decrease) -----3.09%-346.66M----85.00%-64.47M----66.42%-336.27M-----339.71%-429.86M-----474.66%-1B
Advance payment increase (decrease) ----100.37%2.99M----139.87%314.8M-----211.88%-818.82M-------789.66M------731.89M
Cash  from business operations --0-25.47%3.09B--04.41%2.3B--0-30.89%4.14B--0--2.2B--0--5.99B
Other taxs -----175.74%-722.7M-----15.00%-230.09M----57.12%-262.09M-------200.07M-------611.25M
Adjustment items of business operations -116.88%-181.67M-----30.37%2.77B-----14.59%1.08B-----16.72%3.98B----71.14%1.26B----
Net cash from operations -116.88%-181.67M-39.07%2.36B-30.37%2.77B3.35%2.07B-14.59%1.08B-27.91%3.88B-16.72%3.98B-3.96%2B71.14%1.26B29.35%5.38B
Cash flow from investment activities
Interest received - investment -----95.00%11.53M-----75.67%9.36M----1.49%230.57M------38.48M------227.2M
Dividend received - investment ----111.37%90.54M----144.11%44.88M----298.74%42.84M-----93.27%18.39M-----81.56%10.74M
Loan receivable (increase) decrease -----13,925.62%-186.68M----21.01%6.06M-----100.53%-1.33M------5.01M------252.2M
Decrease in deposits (increase) -----130.61%-148.62M-----112.91%-34.21M----343.07%485.52M------265.02M-------199.75M
Sale of fixed assets ----147.47%120.27M----6,586.14%118.68M----117.42%48.6M-----90.73%1.78M----81.83%22.35M
Purchase of fixed assets ----80.04%-40.24M----89.51%-44.58M----53.40%-201.6M----69.51%-425.08M----85.07%-432.57M
Selling intangible assets -----98.28%235K------306K----6,292.06%13.68M--------------214K
Purchase of intangible assets ----96.03%-1.34M-----1,458.28%-15.05M-----333.92%-33.8M-------966K-------7.79M
Sale of subsidiaries ----370.18%633.97M----989.88%81.52M-----74.68%134.83M-----95.36%7.48M----53,248,699,900.00%532.49M
Acquisition of subsidiaries -------12.5M--------------------22.58%-5.5M----66.02%-544.1M
Recovery of cash from investments -----84.57%491.98M-----27.20%851.77M-----37.31%3.19B----118.61%1.17B----205.63%5.09B
Cash on investment ----61.95%-309.73M----41.68%-196.2M----79.97%-814.01M-----66.49%-336.44M-----394.60%-4.06B
Other items in the investment business -302.38%-470.84M102.16%51.94M214.35%536M86.58%-88.06M-42.78%232.66M-138.30%-2.41B-91.98%170.51M-214.39%-656.3M262.58%406.62M20.29%-1.01B
Net cash from investment operations -302.38%-470.84M1.99%701.36M214.35%536M797.67%734.47M-42.78%232.66M642.29%687.7M-91.98%170.51M301.74%81.82M262.58%406.62M97.39%-126.81M
Net cash before financing -149.85%-652.52M-32.88%3.07B-20.30%3.3B34.55%2.8B-21.47%1.31B-13.08%4.57B-39.91%4.15B1.95%2.08B242.82%1.67B859.15%5.25B
Cash flow from financing activities
New borrowing ----9.44%12.21B-----66.11%2.59B-----22.24%11.16B----23.77%7.63B-----22.89%14.35B
Refund ----5.29%-12.18B----50.20%-3.49B----21.02%-12.86B----17.68%-7B-----11.48%-16.28B
Issuing shares --------------------------------------3.68B
Issuance of bonds ----------------------1.7B----------------
Interest paid - financing ----10.85%-2.22B----15.72%-1.25B----0.40%-2.49B-------1.48B-------2.5B
Dividends paid - financing ----70.79%-167.78M----76.54%-17.21M-----168.73%-574.31M----94.96%-73.35M----94.36%-213.72M
Absorb investment income ----11,088.83%305.46M-------------96.50%2.73M-----96.71%2.23M----293.14%78.04M
Issuance expenses and redemption of securities expenses ----87.17%-530.83M----66.61%-500.83M-----3.06%-4.14B-------1.5B-------4.01B
Other items of the financing business 196.62%1.45B31.83%-582.45M44.70%-2.79B-51.42%-247.27M21.76%-1.5B-481.20%-854.4M28.30%-5.05B-181.24%-163.3M-128.37%-1.92B64.44%-147.01M
Net cash from financing operations 196.62%1.45B60.72%-3.17B44.70%-2.79B-12.63%-2.91B21.76%-1.5B-59.47%-8.06B28.30%-5.05B26.71%-2.59B-128.37%-1.92B-2,678.28%-5.05B
Effect of rate 60.21%-292.92K-118.05%-510K-78.75%351.58K1,283.02%627K25.24%-736.13K185.66%2.83M1,128.30%1.65M85.38%-53K-126.83%-984.63K-209.77%-3.3M
Net Cash 514.79%798.1M97.11%-100.95M156.17%509.64M78.06%-110.47M23.69%-192.41M-1,844.33%-3.49B-511.72%-907.33M66.12%-503.52M28.78%-252.14M122.91%200.22M
Begining period cash -3.89%2.51B-57.23%2.61B-57.23%2.61B-57.23%2.61B-57.23%2.61B3.34%6.1B3.34%6.1B3.34%6.1B3.34%6.1B-12.91%5.9B
Cash at the end 36.83%3.3B-3.89%2.51B-39.94%3.12B-55.34%2.5B-58.68%2.42B-57.23%2.61B-9.74%5.19B26.73%5.59B5.30%5.84B3.34%6.1B
Cash balance analysis
Cash and cash equivalent balance --0--0--0--0--0--0--0--0--0--0
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IAS
Audit Opinions --Unqualified Opinion------Unqualified Opinion------Unqualified Opinion
Auditor --National Health Certified Public Accountants Limited, ZTE Caiguanghua Certified Public Accountants (Special General Partnership)------National Health Certified Public Accountants Limited, ZTE Caiguanghua Certified Public Accountants (Special General Partnership)------Ernst & Young (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg